Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Metabolite of spironolactone; Na+/K+ ATPase par...
Endogenous peptide, involved in hormone regulat...
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...
Alkaloid originally found in species of Nicotia...
Endogenous peptide hormone inolved in gastric e...
Endogenous peptide involved in vascular contrac...
Selective and reversible JAK inhibitor.
Synthetic steroid hormone, estrogen analog, use...
STING activator
CDK inhibitor.
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
HDAC inhibitor.
Naphthoquinone found in Plumbago.
Walrycin response regulator inhibitor.
Neuropeptide found in Schistocera gregaria.
CHK1 inhibitor.
Inhibitor of Akt.
Statin; HMG-CoA reductase inhibitor.
Imidzoline derivative; MDM2 inhibitor.
Recombinant BNP, cardiomodulatory peptide; NPR-...